Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316014983> ?p ?o ?g. }
- W4316014983 endingPage "101818" @default.
- W4316014983 startingPage "101818" @default.
- W4316014983 abstract "Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder, predisposing development of benign and malignant tumours. Given the oncogenic potential, long-term surveillance is important in patients with NF1. Proposals for NF1 care and its specific manifestations have been developed, but lack integration within routine care. This guideline aims to assimilate available information on NF1 associated tumours (based on evidence and/or expert opinion) to assist healthcare professionals in undertaking tumour surveillance of NF1 individuals.By comprehensive literature review, performed March 18th 2020, guidelines were developed by a NF1 expert group and patient representatives, conversant with clinical care of the wide NF1 disease spectrum. We used a modified Delphi procedure to overcome issues of variability in recommendations for specific (national) health care settings, and to deal with recommendations based on indirect (scarce) evidence.We defined proposals for personalised and targeted tumour management in NF1, ensuring appropriate care for those in need, whilst reducing unnecessary intervention. We also incorporated the tumour-related psychosocial and quality of life impact of NF1.The guideline reflects the current care for NF1 in Europe. They are not meant to be prescriptive and may be adjusted to local available resources at the treating centre, both within and outside EU countries.This guideline has been supported by the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS). ERN GENTURIS is funded by the European Union. DGE is supported by the Manchester NIHRBiomedical Research Centre (IS-BRC-1215-20007)." @default.
- W4316014983 created "2023-01-14" @default.
- W4316014983 creator A5004753885 @default.
- W4316014983 creator A5005776107 @default.
- W4316014983 creator A5005926923 @default.
- W4316014983 creator A5012735823 @default.
- W4316014983 creator A5013617741 @default.
- W4316014983 creator A5017483202 @default.
- W4316014983 creator A5018786124 @default.
- W4316014983 creator A5020045332 @default.
- W4316014983 creator A5020581898 @default.
- W4316014983 creator A5021027577 @default.
- W4316014983 creator A5026126995 @default.
- W4316014983 creator A5028631467 @default.
- W4316014983 creator A5028793619 @default.
- W4316014983 creator A5033017301 @default.
- W4316014983 creator A5035396358 @default.
- W4316014983 creator A5037210081 @default.
- W4316014983 creator A5039247142 @default.
- W4316014983 creator A5039605544 @default.
- W4316014983 creator A5042455579 @default.
- W4316014983 creator A5043215515 @default.
- W4316014983 creator A5043632375 @default.
- W4316014983 creator A5044236216 @default.
- W4316014983 creator A5044278137 @default.
- W4316014983 creator A5046737384 @default.
- W4316014983 creator A5049755954 @default.
- W4316014983 creator A5050215262 @default.
- W4316014983 creator A5050629531 @default.
- W4316014983 creator A5054509096 @default.
- W4316014983 creator A5056034710 @default.
- W4316014983 creator A5056969576 @default.
- W4316014983 creator A5057691882 @default.
- W4316014983 creator A5059910653 @default.
- W4316014983 creator A5060865546 @default.
- W4316014983 creator A5070254609 @default.
- W4316014983 creator A5072864176 @default.
- W4316014983 creator A5073755970 @default.
- W4316014983 creator A5082633441 @default.
- W4316014983 creator A5083989473 @default.
- W4316014983 date "2023-02-01" @default.
- W4316014983 modified "2023-10-03" @default.
- W4316014983 title "ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1" @default.
- W4316014983 cites W128563030 @default.
- W4316014983 cites W1503338063 @default.
- W4316014983 cites W1520847816 @default.
- W4316014983 cites W1616217629 @default.
- W4316014983 cites W1886042133 @default.
- W4316014983 cites W1892768651 @default.
- W4316014983 cites W1942148246 @default.
- W4316014983 cites W1964502506 @default.
- W4316014983 cites W1967152715 @default.
- W4316014983 cites W1967198299 @default.
- W4316014983 cites W1967830748 @default.
- W4316014983 cites W1969383564 @default.
- W4316014983 cites W1971154531 @default.
- W4316014983 cites W1971418109 @default.
- W4316014983 cites W1986592256 @default.
- W4316014983 cites W1986932232 @default.
- W4316014983 cites W1987322957 @default.
- W4316014983 cites W1987847610 @default.
- W4316014983 cites W1990833369 @default.
- W4316014983 cites W1995607634 @default.
- W4316014983 cites W1995781553 @default.
- W4316014983 cites W1996688898 @default.
- W4316014983 cites W1997887695 @default.
- W4316014983 cites W2002090180 @default.
- W4316014983 cites W2004721099 @default.
- W4316014983 cites W2009216874 @default.
- W4316014983 cites W2010666222 @default.
- W4316014983 cites W2019142701 @default.
- W4316014983 cites W2026686051 @default.
- W4316014983 cites W2028600766 @default.
- W4316014983 cites W2033165622 @default.
- W4316014983 cites W2034029713 @default.
- W4316014983 cites W2035242333 @default.
- W4316014983 cites W2036526089 @default.
- W4316014983 cites W2040733488 @default.
- W4316014983 cites W2044072561 @default.
- W4316014983 cites W2051465756 @default.
- W4316014983 cites W2052954337 @default.
- W4316014983 cites W2055629848 @default.
- W4316014983 cites W2059964588 @default.
- W4316014983 cites W2061573163 @default.
- W4316014983 cites W2063057728 @default.
- W4316014983 cites W2066209628 @default.
- W4316014983 cites W2069371521 @default.
- W4316014983 cites W2072119614 @default.
- W4316014983 cites W2073759645 @default.
- W4316014983 cites W2080625590 @default.
- W4316014983 cites W2082612174 @default.
- W4316014983 cites W2084559564 @default.
- W4316014983 cites W2093250444 @default.
- W4316014983 cites W2095574307 @default.
- W4316014983 cites W2105518445 @default.
- W4316014983 cites W2113286019 @default.
- W4316014983 cites W2114752419 @default.
- W4316014983 cites W2122377651 @default.